| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |